Home › Funds › Saturn V Capital Management LP › ANRO

Saturn V Capital Management LP position in ANRO

ALTO NEUROSCIENCE INC COM SHS · Health Care

Saturn V Capital Management LP reported holding 182,829 shares of ANRO (ALTO NEUROSCIENCE INC COM SHS) in its Q2 2026 13F filing — a position valued at US$4.8M, representing 0.69% of its reported portfolio and ranking #21 among its reported holdings. Saturn V Capital Management LP has disclosed ANRO holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)182.83K sh
Reported value held$4.82M
Portfolio Weight0.69%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Saturn V Capital Management LP's ANRO position evolved

Saturn V Capital Management LP first disclosed a stake in ANRO in Q1 2026 at 88,999 shares (US$2.0M). The position peaked in Q2 2026 at 182,829 shares, worth US$4.8M. Across 2 filings, Saturn V Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 182,829 shares valued at US$4.8M — an increase of 93,830 shares quarter over quarter.. Notable position changes include a 105% increase in Q2 2026 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 89.00K $2.00M New
Q2 2026 182.83K $4.82M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANRO and 13F data

ANRO (ALTO NEUROSCIENCE INC COM SHS) is a Health Care company. 58 other funds we track also report a position in ANRO — the largest reported positions include Alpha Wave Global, LP (US$97.8M), Commodore Capital LP (US$71.9M), PERCEPTIVE ADVISORS LLC (US$42.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANRO

All ANRO fund holders →

FAQ

How long has Saturn V Capital Management LP held ANRO?

Saturn V Capital Management LP has disclosed ANRO holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Saturn V Capital Management LP's current position in ANRO?

As of Q2 2026, Saturn V Capital Management LP holds 182.83K shares of ANRO (ALTO NEUROSCIENCE INC COM SHS), valued at $4.82M, representing 0.69% of its reported portfolio and ranking #21.

Has Saturn V Capital Management LP been buying or selling ANRO?

In the latest 13F filing (Q2 2026), Saturn V Capital Management LP increased its position in ANRO. The position peaked in Q2 2026 at 182.83K shares.

Which other funds hold ANRO?

Other major institutional holders of ANRO include Alpha Wave Global, LP, Commodore Capital LP, PERCEPTIVE ADVISORS LLC, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.